Aptar CSP Technologies Expands Production of Activ-Vialâ„¢ Technology to China

Bringing local production of Activ-Vial™, the world choice for blood glucose test strip protection, to diabetes patients in the China region

Aptar CSP Technologies, part of AptarGroup, Inc. and a leader in active material science solutions to ensure product protection, extend shelf life and improve patient experience, is launching its Activ-Vial system in China. Activ-Vial will be produced at the company’s facility in Guangzhou, providing for the country’s growing diagnostics market, particularly for patients with diabetes conditions where blood glucose monitoring is a critical component of care.

By locally manufacturing Activ-Vial, Aptar CSP Technologies will bring production closer to customers, mitigating supply chain disruptions, and more importantly, providing an optimal solution to the local diabetes patient. The move is a key component of the company’s strategic effort to significantly expand its market presence in China.

“This latest investment in local production expansion reflects our continued commitment to serving the China market,” said Badre Hammond, VP Global Commercial Operations, Aptar CSP Technologies. “This initiative not only represents an investment in the markets and communities we serve, but allows us to leverage local supply chains, improving our cost structure and sustainability of operations.”

Aptar CSP Technologies’ Activ-Vial™ solution features the company’s proprietary 3-Phase Activ-Polymer™ platform technology fully integrated into the vial, creating a microclimate that protects against moisture and other environmental conditions that can impact diabetes test strip stability. Unlike traditional packaging options, this technology co-molds highly-engineered active particles into the vial, completely surrounding the product to scavenge moisture before it ever reaches the contents inside. Additionally, the company’s patented “close in the mold” technology ensures a moisture-tight seal that maintains its integrity throughout shelf life and patient use life to deliver greater product stability. 

For more information, visit www.csptechnologies.com and www.aptar.com.

Subscribe to PFFC's EClips Newsletter